Ligand Pharmaceuticals, Inc.

{
  "main_header": {
    "sid": 1156931,
    "name": "Ligand Pharmaceuticals, Inc.",
    "stock_name": "Ligand Pharmaceuticals, Inc.",
    "full_name": "Ligand Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/ligand-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "198.33",
    "chg": -0.51,
    "chgp": "-0.26%",
    "dir": -1,
    "prev_price": "198.84",
    "mcapval": "3,926.70",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US53220K5048",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "234.95 k",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ligand-pharmaceuticals-inc-1156931-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ligand Pharmaceuticals Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ligand-pharmaceuticals-changes-valuation-grade-from-risky-to-expensive-amid-losses-3686225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LigandPharmaceu_valuationdot_3686225.png",
        "date": "2025-11-10 15:46:25",
        "description": "Ligand Pharmaceuticals, Inc. has adjusted its valuation amid operational challenges, reporting a price-to-book value of 2.57 and an EV to EBITDA of 88.07. Despite difficulties reflected in negative ROCE and ROE, the company has shown strong stock performance, significantly outperforming the S&P 500 year-to-date."
      }
    ],
    "total": 19,
    "sid": "1156931",
    "stock_news_url": "https://www.marketsmojo.com/news/ligand-pharmaceuticals-inc-1156931"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ligand Pharmaceuticals Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-11-10 15:46:25

Ligand Pharmaceuticals, Inc. has adjusted its valuation amid operational challenges, reporting a price-to-book value of 2.57 and an EV to EBITDA of 88.07. Despite difficulties reflected in negative ROCE and ROE, the company has shown strong stock performance, significantly outperforming the S&P 500 year-to-date.

Read full news article

View All News